Free­line un­veils ear­ly ef­fi­ca­cy sig­nal for Gauch­er gene ther­a­py: #AS­GCT24

BAL­TI­MORE — Four pa­tients with Gauch­er dis­ease were able to stop their reg­u­lar treat­ments af­ter re­ceiv­ing a one-time in­fu­sion of a gene ther­a­py de­vel­oped by Free­line …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER